INOVIO to Participate in Upcoming Investor Conferences

Rhea-AI Summary

INOVIO (NASDAQ: INO) announced participation in two investor events in New York. The company will join the Cantor Global Healthcare Conference on Wednesday, September 9, featuring a fireside chat at 3:20 PM ET with a live webcast. INOVIO will also present at the H.C. Wainwright 28th Annual Global Investment Conference, with a virtual presentation available starting Friday, September 11 at 7:00 AM ET. Webcast and virtual links will host replays for 90 days, and management plans to hold one-on-one meetings with investors during both conferences.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences:

Cantor Global Healthcare Conference (New York)
Date: Wednesday, September 9
Fireside Chat: 3:20 PM ET
Webcast: https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=99315971&checkCompany=1&checkEmail=1&checkName=1

H.C. Wainwright 28^th Annual Global Investment Conference (New York)
Presentation Available: Beginning Friday, September 11, 7:00 AM ET
Format: Virtual
Link: https://journey.ct.events/view/eb47953c-3213-432d-92ca-13beb55c97ae 

Replays of the investor presentations will be available for 90 days at the links above. During these conferences members of INOVIO's management team will also be conducting one-on-one meetings with investors.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, investor.relations@inovio.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-investor-conferences-302866521.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO (NASDAQ: INO) present at the Cantor Global Healthcare Conference 2026?

INOVIO will participate in the Cantor Global Healthcare Conference on Wednesday, September 9, with a fireside chat at 3:20 PM ET. According to INOVIO, the session will be accessible via a live webcast using the provided online link.

How can investors access the INOVIO (INO) Cantor Global Healthcare Conference 2026 webcast?

Investors can access INOVIO’s Cantor Global Healthcare Conference webcast via the specified secure streaming link. According to INOVIO, the fireside chat at 3:20 PM ET on September 9 will be streamed live and remain available for replay for 90 days.

What are the details of INOVIO’s presentation at the H.C. Wainwright 28th Annual Global Investment Conference 2026?

INOVIO’s presentation will be available starting Friday, September 11 at 7:00 AM ET in virtual format. According to INOVIO, investors can view the presentation through the provided event link, with on-demand replay access for 90 days following availability.

Will replays of INOVIO’s September 2026 investor conference presentations be available to shareholders?

Yes, replays of INOVIO’s investor presentations from both conferences will be available for 90 days. According to INOVIO, shareholders can use the same webcast and virtual event links to access on-demand recordings after the live sessions.

Is INOVIO management holding one-on-one investor meetings during the September 2026 conferences?

Yes, INOVIO stated that members of its management team will conduct one-on-one meetings with investors during both conferences. According to INOVIO, these meetings complement the public fireside chat and virtual presentation sessions.

What type of company is INOVIO (NASDAQ: INO) participating in these 2026 investor conferences?

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines. According to INOVIO, its programs aim to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, topics often discussed at investor conferences.